Table II.
Constructsa | AB loop | CD loop | EF loop | FG loop |
---|---|---|---|---|
WTb | TPTS | GGNSP | GLKPG | GRGDSPASSK |
FG (MOP3) | SGGGSFAEYWALLSGGGSc | |||
FGC (MOP3C) | SGGGSAAEYAALASGGGSd | |||
AB | SGGGSFAEYWALLSGGGS | |||
AB2 | TPSFAEYWALLSTS | |||
AB:FG | SGGGSFAEYWALLSGGGS | SGGGSFAEYWALLSGGGS | ||
AB2:FG | TPSFAEYWALLSTS | SGGGSFAEYWALLSGGGS | ||
CD | SGGGSFAEYWALLSGGGS | |||
CDC | SGGGSAAEYAALASGGGS | |||
CD:FG (MOP3+) | SGGGSFAEYWALLSGGGS | SGGGSFAEYWALLSGGGS | ||
CDC:FG | SGGGSAAEYAALASGGGS | SGGGSFAEYWALLSGGGS | ||
EF | SGGGSFAEYWALLSGGGS | |||
EF2 | GLSFAEYWALLSKPG | |||
EF: FG | SGGGSFAEYWALLSGGGS | SGGGSFAEYWALLSGGGS | ||
EF2:FG | GLSFAEYWALLSKPG | SGGGSFAEYWALLSGGGS |
aName of 10FN3 domain inhibitors based on loop where a replacement (AB, CD, EF or FG) or insertion was made (AB2, EF2).
bWild-type sequences of AB, CD, EF and FG loop region.
cSGGGSFAEYWALLSGGGS = SGGG-M2-GGGS.
dSGGGSAAEYAALASGGGS = SGGG-M2C-GGGS.